| 0 |
HAEMANGIOMA RUPTURE |
3 |
0.1875 |
| 1 |
VULVOVAGINAL EXFOLIATION |
3 |
0.0577 |
| 2 |
EYELID SENSORY DISORDER |
3 |
0.0152 |
| 3 |
GREATER TROCHANTERIC PAIN SYNDROME |
3 |
0.0146 |
| 4 |
OESTROGEN DEFICIENCY |
3 |
0.0109 |
| 5 |
FROSTBITE |
3 |
0.0100 |
| 6 |
PIK3CA-ACTIVATED MUTATION |
3 |
0.0090 |
| 7 |
RECTOCELE |
3 |
0.0050 |
| 8 |
NASAL INJURY |
3 |
0.0042 |
| 9 |
HYPERMETROPIA |
3 |
0.0032 |
| 10 |
APPLICATION SITE BRUISE |
3 |
0.0031 |
| 11 |
REFLUX GASTRITIS |
3 |
0.0025 |
| 12 |
NASAL PRURITUS |
3 |
0.0024 |
| 13 |
ASTIGMATISM |
3 |
0.0020 |
| 14 |
SPINAL CORD DISORDER |
3 |
0.0018 |
| 15 |
SPINAL CORD INJURY |
3 |
0.0017 |
| 16 |
HAEMANGIOMA |
3 |
0.0013 |
| 17 |
DISCOURAGEMENT |
3 |
0.0013 |
| 18 |
NASAL DISORDER |
3 |
0.0011 |
| 19 |
TRICHORRHEXIS |
3 |
0.0011 |
| 20 |
WAIST CIRCUMFERENCE INCREASED |
1 |
0.0010 |
| 21 |
VULVOVAGINAL DRYNESS |
3 |
0.0009 |
| 22 |
METASTASES TO SPINE |
3 |
0.0009 |
| 23 |
FACE INJURY |
3 |
0.0008 |
| 24 |
PANIC DISORDER |
3 |
0.0008 |
| 25 |
VULVOVAGINAL DISCOMFORT |
3 |
0.0007 |
| 26 |
RHINITIS ALLERGIC |
3 |
0.0007 |
| 27 |
EAR DISORDER |
3 |
0.0007 |
| 28 |
TUMOUR MARKER INCREASED |
3 |
0.0006 |
| 29 |
APPLICATION SITE SWELLING |
3 |
0.0006 |
| 30 |
VEIN DISORDER |
3 |
0.0006 |
| 31 |
PHLEBITIS |
3 |
0.0006 |
| 32 |
ASTHENOPIA |
3 |
0.0005 |
| 33 |
SKIN ATROPHY |
3 |
0.0005 |
| 34 |
VULVOVAGINAL BURNING SENSATION |
3 |
0.0005 |
| 35 |
NASAL DRYNESS |
3 |
0.0005 |
| 36 |
SWELLING OF EYELID |
3 |
0.0005 |
| 37 |
METASTASIS |
3 |
0.0004 |
| 38 |
APHTHOUS ULCER |
3 |
0.0004 |
| 39 |
NASAL DISCOMFORT |
3 |
0.0004 |
| 40 |
RHINITIS |
3 |
0.0004 |
| 41 |
LIP DRY |
3 |
0.0003 |
| 42 |
EYELID PTOSIS |
3 |
0.0003 |
| 43 |
DRY THROAT |
3 |
0.0003 |
| 44 |
SKELETAL INJURY |
3 |
0.0003 |
| 45 |
PETECHIAE |
3 |
0.0003 |
| 46 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 47 |
NEOPLASM |
3 |
0.0003 |
| 48 |
HIATUS HERNIA |
3 |
0.0002 |
| 49 |
HAIR TEXTURE ABNORMAL |
3 |
0.0002 |
| 50 |
ANOSMIA |
3 |
0.0002 |
| 51 |
IMMUNODEFICIENCY |
3 |
0.0002 |
| 52 |
METASTASES TO BONE |
3 |
0.0002 |
| 53 |
METASTASES TO LIVER |
3 |
0.0002 |
| 54 |
HEAD DISCOMFORT |
3 |
0.0002 |
| 55 |
HAEMORRHOIDS |
3 |
0.0002 |
| 56 |
ORAL HERPES |
3 |
0.0002 |
| 57 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 58 |
FEEDING DISORDER |
3 |
0.0001 |
| 59 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 60 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 61 |
ORAL PAIN |
3 |
0.0001 |
| 62 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 63 |
LIVER INJURY |
3 |
0.0001 |
| 64 |
HAEMATOMA |
3 |
0.0001 |
| 65 |
SKIN LESION |
3 |
0.0001 |
| 66 |
WOUND |
3 |
0.0001 |
| 67 |
DYSSTASIA |
3 |
0.0001 |
| 68 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 69 |
HEAD INJURY |
3 |
0.0001 |
| 70 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 71 |
SKIN DISORDER |
3 |
0.0001 |
| 72 |
EYE SWELLING |
3 |
0.0001 |
| 73 |
NEUTROPHIL COUNT DECREASED |
3 |
0.0001 |
| 74 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 75 |
GASTROENTERITIS |
1 |
0.0001 |
| 76 |
OCULAR HYPERAEMIA |
3 |
0.0001 |
| 77 |
DRY EYE |
3 |
0.0001 |
| 78 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 79 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 80 |
BONE PAIN |
3 |
0.0001 |
| 81 |
KIDNEY INFECTION |
1 |
0.0001 |
| 82 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 83 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 84 |
INJURY |
3 |
0.0000 |
| 85 |
EPISTAXIS |
3 |
0.0000 |
| 86 |
ILLNESS |
4 |
0.0000 |
| 87 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 88 |
DRY MOUTH |
3 |
0.0000 |
| 89 |
DIVERTICULITIS |
1 |
0.0000 |
| 90 |
NEEDLE ISSUE |
1 |
0.0000 |
| 91 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 92 |
SWELLING |
3 |
0.0000 |
| 93 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 94 |
VIRAL INFECTION |
1 |
0.0000 |
| 95 |
SINUSITIS |
3 |
0.0000 |
| 96 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 97 |
CHILLS |
3 |
0.0000 |
| 98 |
DISEASE PROGRESSION |
3 |
0.0000 |
| 99 |
DISORIENTATION |
1 |
0.0000 |
| 100 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 101 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 102 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 103 |
DRY SKIN |
3 |
0.0000 |
| 104 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 105 |
FLUID RETENTION |
1 |
0.0000 |
| 106 |
PARAESTHESIA |
3 |
0.0000 |
| 107 |
RASH PRURITIC |
1 |
0.0000 |
| 108 |
MEDICATION ERROR |
1 |
0.0000 |
| 109 |
WEIGHT DECREASED |
5 |
0.0000 |
| 110 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 111 |
VERTIGO |
1 |
0.0000 |
| 112 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 113 |
ALOPECIA |
3 |
0.0000 |
| 114 |
ERYTHEMA |
3 |
0.0000 |
| 115 |
CONSTIPATION |
3 |
0.0000 |
| 116 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 117 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 118 |
PRURITUS |
5 |
0.0000 |
| 119 |
ARTHRITIS |
1 |
0.0000 |
| 120 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 121 |
INSOMNIA |
3 |
0.0000 |
| 122 |
BREAST CANCER |
1 |
0.0000 |
| 123 |
DYSPHAGIA |
1 |
0.0000 |
| 124 |
MIGRAINE |
1 |
0.0000 |
| 125 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 126 |
HEART RATE INCREASED |
1 |
0.0000 |
| 127 |
FLUSHING |
1 |
0.0000 |
| 128 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 129 |
PYREXIA |
3 |
0.0000 |
| 130 |
PALPITATIONS |
1 |
0.0000 |
| 131 |
JOINT SWELLING |
1 |
0.0000 |
| 132 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 133 |
ARTHRALGIA |
3 |
0.0000 |
| 134 |
DYSPNOEA |
4 |
0.0000 |
| 135 |
MALAISE |
3 |
0.0000 |
| 136 |
HYPOAESTHESIA |
1 |
0.0000 |
| 137 |
PAIN |
4 |
0.0000 |
| 138 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 139 |
FATIGUE |
5 |
0.0000 |
| 140 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 141 |
COVID-19 |
1 |
0.0000 |
| 142 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 143 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 144 |
SOMNOLENCE |
1 |
0.0000 |
| 145 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 146 |
HYPERTENSION |
1 |
0.0000 |
| 147 |
RASH |
2 |
0.0000 |
| 148 |
WEIGHT INCREASED |
1 |
0.0000 |
| 149 |
DECREASED APPETITE |
1 |
0.0000 |
| 150 |
VOMITING |
2 |
0.0000 |
| 151 |
FEELING ABNORMAL |
1 |
0.0000 |
| 152 |
NAUSEA |
2 |
0.0000 |
| 153 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 154 |
DIZZINESS |
1 |
0.0000 |
| 155 |
HEADACHE |
1 |
0.0000 |
| 156 |
DIARRHOEA |
1 |
0.0000 |
| 157 |
DEATH |
1 |
0.0000 |